Delving into the Latest Updates on Jinchai Kanggan Capsule with Synapse

Overview

Basic Info

Drug Type

Herbal medicine

Synonyms-

Target-

Mechanism-

Therapeutic Areas

Infectious DiseasesRespiratory Diseases

Active Indication-

Inactive Indication

Common Cold

Originator Organization-

Active Organization-

Inactive Organization

Wuhan Shuanglong Pharmaceutical Co., Ltd.

Wuhan Medicine Valley Technology Development Co., Ltd.

Drug Highest PhasePendingPhase 2

First Approval Date-

Regulation-

Login to view timeline

1．评价金柴抗感胶囊改善普通感冒症状、缩短普通感冒热程的作用，并进行剂量探索； 2．探索金柴抗感胶囊对于普通感冒的即时退热作用； 3．探索金柴抗感胶囊改善感冒风热证的疗效； 4．观察金柴抗感胶囊的安全性及不良反应。

[Translation]

1. To evaluate the effect of Jinchai Kanggan Capsule in improving the symptoms of common cold and shortening the fever course of common cold, and to explore the dosage; 2. To explore the immediate antipyretic effect of Jinchai Kanggan Capsule on common cold; 3. To explore the efficacy of Jinchai Kanggan Capsule in improving wind-heat syndrome of cold; 4. To observe the safety and adverse reactions of Jinchai Kanggan Capsule.

Start Date07 Nov 2014

Sponsor / Collaborator

Wuhan Medicine Valley Technology Development Co., Ltd.

[+1]

100 Clinical Results associated with Jinchai Kanggan Capsule

Login to view more data

100 Translational Medicine associated with Jinchai Kanggan Capsule

Login to view more data

100 Patents (Medical) associated with Jinchai Kanggan Capsule

Login to view more data

100 Deals associated with Jinchai Kanggan Capsule

Login to view more data

R&D Status

10 top R&D records.

Login

to view more data

Indication	Highest Phase	Country/Location	Organization	Date
Common Cold	Phase 2	CN	Wuhan Medicine Valley Technology Development Co., Ltd.	07 Nov 2014
Common Cold	Phase 2	CN	Wuhan Shuanglong Pharmaceutical Co., Ltd.	07 Nov 2014